Related Experiment Video
Updated: Apr 4, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
Insup Choi1,2,3, Beomsue Kim2, Ji-Won Byun1,2
1Department of Biomedical Sciences, Neuroscience Graduate Program, Ajou University School of Medicine, Suwon, Gyeonggi-do 443-380, Korea.
Abstract:
In response to brain injury, microglia rapidly extend processes that isolate lesion sites and protect the brain from further injury. Here we report that microglia carrying a pathogenic mutation in the Parkinson's disease (PD)-associated gene, G2019S-LRRK2 (GS-Tg microglia), show retarded ADP-induced motility and delayed isolation of injury, compared with non-Tg microglia. Conversely, LRRK2 knockdown microglia are highly motile compared with control cells. In our functional assays, LRRK2 binds to focal adhesion kinase (FAK) and phosphorylates its Thr-X-Arg/Lys (TXR/K) motif(s), eventually attenuating FAK activity marked by decreased pY397 phosphorylation (pY397). GS-LRRK2 decreases the levels of pY397 in the brain, microglia and HEK cells. In addition, treatment with an inhibitor of LRRK2 kinase restores pY397 levels, decreased pTXR levels and rescued motility of GS-Tg microglia. These results collectively suggest that G2019S mutation of LRRK2 may contribute to the development of PD by inhibiting microglial response to brain injury.
Insights
Parkinson's disease mutations in the LRRK2 gene impair microglial cell motility and response to brain injury. This dysfunction may contribute to Parkinson's disease development by hindering protective brain mechanisms.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Microglia are key immune cells in the brain, crucial for responding to injury.
- The G2019S mutation in LRRK2 is a common cause of familial and sporadic Parkinson's disease.
- LRRK2's role in microglial function and its link to Parkinson's disease pathology remain incompletely understood.
Purpose of the Study:
- To investigate the impact of the G2019S-LRRK2 mutation on microglial cell function and response to brain injury.
- To elucidate the molecular mechanisms by which LRRK2 affects microglial motility and injury response.
Main Methods:
- Utilized G2019S-LRRK2 transgenic (GS-Tg) and LRRK2 knockdown microglia models.
- Performed ADP-induced motility assays and lesion isolation experiments.
- Investigated LRRK2 binding and phosphorylation of focal adhesion kinase (FAK) using biochemical assays and Western blotting for pY397 levels.
Main Results:
- GS-Tg microglia exhibited reduced motility and delayed injury isolation compared to non-Tg microglia.
- LRRK2 knockdown microglia demonstrated enhanced motility.
- LRRK2 directly binds and phosphorylates FAK, attenuating its activity (decreased pY397).
- GS-LRRK2 mutation reduced pY397 levels in brain, microglia, and HEK cells.
- LRRK2 kinase inhibition restored pY397 levels and rescued microglial motility.
Conclusions:
- The G2019S mutation in LRRK2 impairs microglial response to brain injury by inhibiting FAK signaling.
- This impaired microglial function may represent a novel mechanism contributing to Parkinson's disease pathogenesis.
- Targeting LRRK2 kinase activity could be a therapeutic strategy for Parkinson's disease.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Microtubules in Cell Motility

